Literature DB >> 25745341

Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis.

Vural Taner Yilmaz1, Dinc Dincer2, Ali Berkant Avci3, Ramazan Cetinkaya1.   

Abstract

OBJECTIVE: Von Willebrand factor (vWF) is a mediator that increases endotoxemic medium like in cirrhosis. In this study we evaluated the association of serum VWF antigen (Ag) level with the stage of cirrhosis (according to Child-Pugh classification).
MATERIALS AND METHODS: We included 82 cirrhotic patients (Female/Male (F/M): 26/56) and 86 healthy subjects (F/M: 44/42) in the study. Ages of the both groups of patients were not different (P= 0.095). We excluded possible other reasons that may cause VWF level increase. Diagnosis of cirrhosis was made on the basis of biopsy in 7 patients and with clinical and laboratory parameters in 75 patients. VWF Ag level was determined by immunoturbidimetric test. The stage of cirrhosis was defined with Child-Pugh classification. Data were analysed by using Statistical Package for the Social Sciences (SPSS) 10.0 software program.
RESULTS: VWF Ag level was significantly higher in cirrhotic patients compared to control group (220±90 and 87±38, P<0.001, respectively). We observed significant increase of VWF Ag level with the increasing stages of cirrhosis according to Child-Pugh score (VWF Ag level for Child A-B-C 156.4±54/215±45/284.8±93, respectively; P values for Child A-B/A-C/B-C; <0.001/<0.001/0.006, respectively).
CONCLUSION: Serum VWF Ag level increases in cirrhotic patients and this is more pronounced with higher stages of cirrhosis.

Entities:  

Keywords:  Child Pugh classification; Cirrhosis; von Willebrand factor

Year:  2015        PMID: 25745341      PMCID: PMC4341924          DOI: 10.5152/eajm.2014.0016

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  16 in total

1.  Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence.

Authors:  J M Llovet; R Bartolí; F March; R Planas; B Viñado; E Cabré; J Arnal; P Coll; V Ausina; M A Gassull
Journal:  J Hepatol       Date:  1998-02       Impact factor: 25.083

2.  Assessment of prognosis in advanced liver disease: to score or to measure, that's the question.

Authors:  J Bircher
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

Review 3.  The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis.

Authors:  A Bomzon; L M Blendis
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

4.  Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction.

Authors:  P Villa; J Iborra; J Serra; A Gilsanz; P Casaña; J A Aznar; J Aznar
Journal:  Haematologica       Date:  2001-11       Impact factor: 9.941

5.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.

Authors:  I Albers; H Hartmann; J Bircher; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

6.  Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

Authors:  B Campillo; P Pernet; P N Bories; J P Richardet; M Devanlay; C Aussel
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

7.  Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.

Authors:  L Albornoz; D Alvarez; J C Otaso; A Gadano; J Salviú; S Gerona; P Sorroche; A Villamil; R Mastai
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

8.  Bacterial translocation of enteric organisms in patients with cirrhosis.

Authors:  I Cirera; T M Bauer; M Navasa; J Vila; L Grande; P Taurá; J Fuster; J C García-Valdecasas; A Lacy; M J Suárez; A Rimola; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

Review 9.  Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment.

Authors:  A Tefferi; W L Nichols
Journal:  Am J Med       Date:  1997-12       Impact factor: 4.965

10.  Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L H Nolasco; J D Hellums
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

View more
  3 in total

1.  Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Liver.

Authors:  Daniel F Alonso
Journal:  Eurasian J Med       Date:  2015-10

2.  The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.

Authors:  Patrick Starlinger; Joseph C Ahn; Aidan Mullan; Georg P Gyoeri; David Pereyra; Roberto Alva-Ruiz; Hubert Hackl; Thomas Reiberger; Michael Trauner; Jonas Santol; Benedikt Simbrunner; Mattias Mandorfer; Gabriela Berlakovich; Patrick S Kamath; Julie Heimbach
Journal:  Hepatology       Date:  2021-08-29       Impact factor: 17.425

3.  Von Willebrand factor and esophageal varices in children with chronic liver diseases.

Authors:  Mohamed Abdel-Salam El-Guindi; Nermin Mohammed Adawy; Iman Shaban Osheba; Wafaa Masoud Khalifa; Hosam Eldin Mohammed Basiouny
Journal:  Clin Exp Hepatol       Date:  2021-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.